Cargando…

Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy

Detalles Bibliográficos
Autores principales:	Shi, Yaoping, Shi, Donghua, Chi, Jiachang, Cui, Dan, Tang, Xiaoyin, Lin, Yan, Wang, Siying, Li, Zonghai, Jin, Haojie, Zhai, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508142/ https://www.ncbi.nlm.nih.gov/pubmed/37478283 http://dx.doi.org/10.1002/cac2.12472

Ejemplares similares

Comparison study of computed tomography‐guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case‐controlled observational study
por: Chi, Jiachang, et al.
Publicado: (2018)

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
por: Sun, Ming, et al.
Publicado: (2023)

Risk Assessment and Hydrodissection Technique for Radiofrequency Ablation of Thyroid Benign Nodules
por: Xiaoyin, Tang, et al.
Publicado: (2018)

Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
por: Bi, Yanyu, et al.
Publicado: (2017)

Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma
por: Meng, Min, et al.
Publicado: (2021)

Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
por: Park, Jun Young, et al.
Publicado: (2020)

Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study
por: Shen, Xiaozhang, et al.
Publicado: (2018)

Bispecific GPC3/PD-1 CAR-T cells for the treatment of HCC
por: Li, Dezhi, et al.
Publicado: (2023)

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
por: Jiang, Zhiwu, et al.
Publicado: (2017)

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
por: Li, You-Cai, et al.
Publicado: (2018)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients
por: Ding, Min, et al.
Publicado: (2016)

Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro
por: Wang, Tao, et al.
Publicado: (2017)

Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9
por: Wang, Tao, et al.
Publicado: (2016)

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
por: Sawada, Yu, et al.
Publicado: (2016)

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
por: Li, Weizhen, et al.
Publicado: (2021)

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
por: Ofuji, Kazuya, et al.
Publicado: (2014)

Targeting Therapy to The Neuromuscular Junction: Proof of Concept
por: Kusner, Linda L, et al.
Publicado: (2014)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia, Lijie, et al.
Publicado: (2020)

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules
por: Tang, Xiaoyin, et al.
Publicado: (2017)

Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors
por: Sun, Yansha, et al.
Publicado: (2022)

Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer
por: Qiu, Wenli, et al.
Publicado: (2018)

Proton Grid Therapy: A Proof-of-Concept Study
por: Henry, Thomas, et al.
Publicado: (2016)

Targeting GPC3(high) cancer-associated fibroblasts sensitizing the PD-1 blockage therapy in gastric cancer
por: Li, Dinuo, et al.
Publicado: (2023)

Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
por: Yaguchi, Tomonori, et al.
Publicado: (2015)

IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS
por: Foster, Jessica, et al.
Publicado: (2021)

Multi-Modal Microfluidics (M(3)) for Sample Preparation of Liquid Biopsy: Bridging the Gap between Proof-of-Concept Demonstrations and Practical Applications
por: Liu, Yaoping, et al.
Publicado: (2022)

Malin restoration as proof of concept for gene therapy for Lafora disease
por: Varea, Olga, et al.
Publicado: (2022)

Proton Minibeam Radiation Therapy and Arc Therapy: Proof of Concept of a Winning Alliance
por: Ortiz, Ramon, et al.
Publicado: (2021)

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao, Menglong, et al.
Publicado: (2018)

Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinoma
por: Shin, Woo-Ri, et al.
Publicado: (2022)

ENGINEERING T CELLS TARGETING GPC2 FOR TREATING NEUROBLASTOMA
por: Quan, Alex, et al.
Publicado: (2023)

Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC
por: Wang, Yuliang, et al.
Publicado: (2011)

Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal
por: Wang, Tao, et al.
Publicado: (2016)

Reservoir Cannulas for Pediatric Oxygen Therapy: A Proof-of-Concept Study
por: Wu, Grace, et al.
Publicado: (2016)

Macrophage-based therapy for intervertebral disc herniation: preclinical proof-of-concept
por: Ribeiro-Machado, Cláudia, et al.
Publicado: (2023)

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering
por: Michels, Kathryn R, et al.
Publicado: (2023)

The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
por: Yi, Bin, et al.
Publicado: (2021)

GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay
por: Cao, Guozheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k71kgbmos86e05udqt0e1ojpv4